Chang et al. demonstrated that Map3k1 is a target gene of miR-145-5p and that its overexpression negatively regulates miR-145-5p expression through the JNK signaling pathway, thereby inhibiting EMT in non-small cell lung cancer cells [35]. This evidence concerns the gene MAP3K1 and non-small cell lung carcinoma.